key: cord-0843947-maeviaql
authors: Landes, Scott D.; Turk, Margaret A.; Wong, Ashlyn W.W.A.
title: COVID-19 Outcomes among People with Intellectual and Developmental Disability in California: The Importance of Type of Residence and Skilled Nursing Care Needs
date: 2020-12-05
journal: Disabil Health J
DOI: 10.1016/j.dhjo.2020.101051
sha: 2232ae5f70b55327e1d525a021c3518c4979fdf6
doc_id: 843947
cord_uid: maeviaql

BACKGROUND: People with intellectual and developmental disabilities (IDD) appear to be at greater risk for severe outcomes from COVID-19. The roles of congregate living and skilled nursing care needs is unclear. OBJECTIVE: To determine the impact of residential setting and level of skilled nursing care on COVID-19 outcomes for people receiving IDD services, compared to those not receiving IDD services. METHODS: Utilizing publicly available California data on COVID-19 outcomes for people receiving IDD services (early May through October 2, 2020), we determined outcomes based on seven types of residence, differentiated by number of residents and level of skilled nursing care provided. We compared these results to the larger California published outcomes. RESULTS: Compared to Californians not receiving IDD services, in general, those receiving IDD services had a 60% lower case rate, but 2.8 times higher case-fatality rate. COVID-19 outcomes varied significantly among Californians receiving IDD services by type of residence and skilled nursing care needs: higher rates of diagnosis in settings with larger number of residents, higher case-fatality and mortality rates in settings that provided 24-hour skilled nursing care. CONCLUSIONS: Diagnosis with COVID-19 among Californians receiving IDD services appears to be related to number of individuals within the residence, while adverse COVID-19 outcomes were associated with level of skilled nursing care. When data is available, future research should examine whether these relationships persist even when controlling for age and pre-existing conditions.

Due to a lack of health surveillance, 1 attempting to understand COVID-19 outcomes among people with intellectual and developmental disabilities (IDD) in the US is similar to piecing together a complex puzzle. Despite the challenge, it is essential to investigate the effects of the pandemic on this vulnerable health population, 2 as people with IDD have higher prevalence of chronic health conditions, 3, 4 and a disproportionate percentage of the population resides in congregate settings. 5 Two early studies provide critical baseline information.

An initial study analyzed comorbidity trends and case-fatality rates among people with and without IDD through May 14, 2020 utilizing the TriNetX global health research network composed of real-time electronic medical records. 6 Among those with COVID-19, people with IDD had higher prevalence of cardiovascular disease, respiratory diseases, diabetes or other metabolic and endocrinologic disorders than those without IDD. In addition, COVID-19 casefatality rates were higher among people with than without IDD at ages 0-17 and 18-74, but similar at ages 75 and over. A second study focused on COVID-19 outcomes among adults with IDD living in residential group homes in New York State through May 28, 2020. 7 People with IDD living in residential group homes, compared to New York state overall, had a higher case rate (7,841 per 100,000, 95% CI 7,480-8,218, compared to 1,910 per 100,000, 95% CI 1,910-1,916), case-fatality rate (15.0, 95% CI 13.3-16.8, compared to 7.9, 95% CI 7.8-8.0), and mortality rate (1,175 per 100,000, 95% CI 1,036-1,332, compared to 151 per 100,000, 95% CI 150-153). A recent report from the authors of the New York study detailed that, as of July 10, the J o u r n a l P r e -p r o o f case rate and case-fatality rate remained higher for people with IDD living in residential group homes. 8 These studies provided initial empirical evidence that people with IDD may be at greater risk during the pandemic, but they were not able to differentiate COVID-19 outcomes among people with IDD by residential setting. Compared to the general population, a disproportionate percentage of people with IDD live in congregate setting, such as residential group homes. 5 Beyond the fact that people with IDD, in general, are a vulnerable health population, 2 individuals with IDD living in congregate settings typically have more intensive care needs and poorer health outcomes than those living at home. [9] [10] [11] [12] In addition, living in a congregate setting may increase the risk of COVID-19 transmission due to limitations on physical distancing. [13] [14] [15] While true that a disproportionate percentage of people with IDD live in congregate settings, an estimated 77% of people with IDD who receive long-term supports and services reside in noncongregate settings, such as their own home, in the home of a family member, or in the home of a host or foster family. 16 Distancing concerns may not be as pressing for people with IDD living in their own or a family home, although there may still be a need for personal and/or skilled nursing care, which could increase the number of people that come in/out of the home. The current study utilized data from one US state to compare COVID-19 outcomes among people who were/were not receiving IDD services, then to examine whether differentials in outcomes varied by type of residence for people who were receiving IDD services. Our hypothesis was that COVID-19 outcomes for people receiving IDD services would be more severe for those living in settings that have more residents and/or provide more intensive skilled nursing care.

J o u r n a l P r e -p r o o f

The most populous US state, California, provides services for more people with IDD than any other US state, accounting for 18.3% of all people with IDD receiving long term supports and services in the US. 16 The California Department of Developmental Disabilities Services (DDS) has provided publicly available data on COVID-19 for people with IDD served by the state since early May, 2020. 17 For this study, we utilized the publicly available California DDS data on COVID-19 outcomes for people with IDD receiving services from the state as of October 2, 2020, inclusive of number served, number of cases, and number of deaths, reported overall and by type of service received. COVID-19 data for the state of California overall is from the California Open Data Portal, 18 providing the number of cases and deaths for the entire state as of COVID-19 outcomes analyzed included case rate per 100,000 (cases/population*100,000), casefatality rate (deaths/cases), and mortality rate per 100,000 (deaths/population*100,000).

COVID-19 outcomes for Californians receiving IDD services are reported overall and by type of services received. We identified seven distinct categories of residence type based on the types of Table 1 provides details for each category, inclusive of the type of service received, type of residence, number of residents, and whether skilled nursing care is/is not provided and the intensity of that care in the residence. [19] [20] [21] [22] - Table 1 about here -We first compared COVID-19 outcomes for Californians who were/were not receiving IDD services overall. We then examined differences in COVID-19 outcomes among Californians receiving IDD services by type of residence. Confidence intervals for point estimates were calculated assuming a standard normal distribution for Californians not receiving IDD services and using Wilson's score method for Californians receiving IDD services due to the smaller sample size. In instances when confidence intervals overlapped, 23 we utilized t-test to determine whether difference in point estimates were statistically significant. All analysis was conducted utilizing STATA 16.0 (College Station, TX).

All results are reported in Table 2 . Among Californians not receiving IDD services, the COVID-19 case rate was 2,085 cases per 100,000 people, the case-fatality rate was 1.9%, and the mortality rate was 41 deaths per 100,000 people. Among all Californians receiving IDD services, the case rate was 831 cases per 100,000 people, the case-fatality rate was 5.5%, and the mortality rate was 46 deaths per 100,000. Thus, compared to Californians not receiving IDD services, the risk ratios for Californians receiving IDD services were: 60% lower for case rate (95% CI 0.38 -J o u r n a l P r e -p r o o f 0.41); 2.8 times higher for case-fatality rate (2.43 -3.28); and 1.1 times higher, but not statistically significant, for mortality rate (0.96 -1.31).

- Table 2 Case-fatality rates also varied across settings, but were highest in the settings in which people with IDD received a comparatively higher intensity of skilled nursing care. Apart from Californians receiving IDD services in their own or a family home, the case-fatality rate was lowest among those living in CCF (4.3%) and ICF-DD (4.7%) settings, which provides either no or intermittent skilled nursing care. The mid-range case rate was in the ICF/DD-H setting (6.2%), which provides intermittent skilled nursing care. Higher case-fatality rates were apparent for Californians with IDD receiving services in facilities that provided 24-hour skilled nursing supervision or care (ICF/DD-N -15.8%; SNF -20.4%). Differences in points estimates of the case-fatality rate between own or family home, CCF, and ICF-DD were not statistically significant. Neither were differences in the case-fatality rate between ICF/DD-N and SNF.

Mortality rates varied across settings as well, but were highest in the setting with the most intense levels of skilled nursing. Beyond those living in their own or a family home, the lowest mortality rate, 97 per 100,000, was among those living in a CCF, which does not provide skilled nursing care. The mid-range mortality rate was among those living in ICFs: ICF/DD-H (348 per 100,000) which provides intermittent skilled nursing care; ICF/DD-N (693 per 100,000), which provides 24-hour skilled nursing supervision; and the ICF-DD setting (898 per 100,000), which provides intermittent skilled nursing care. The highest mortality rate, 5,626 per 100,000, was for those living in SNFs, which provides 24-hour skilled nursing and supportive care. Differences in J o u r n a l P r e -p r o o f points estimates of the mortality rates for ICF/DD-H, ICF/DD-N, and ICF-DD were not statistically significant.

Results from this study provide evidence that COVID-19 outcomes varied among Californians receiving IDD services by type of residence and skilled nursing care needs. The least severe COVID-19 outcomes were among Californians with IDD who lived in their own or a family home, a group that accounted for 89% of those receiving IDD services. Californians with IDD who lived in their own or a family home had a case rate and mortality rate lower than that for Californians not receiving IDD services, and only a slightly higher case-fatality rate. COVID-19 outcomes were more severe for Californians receiving IDD services who lived in congregate settings with varying degrees of skilled nursing care needs. For these individuals, the highest case rates were among those living in settings with more residents, whereas the highest casefatality and mortality rates were among those living in settings that provided the most intensive skilled nursing care.

There are few studies that have analyzed data related to outcomes of people with disability and COVID-19. The data that is available often offers limited details of those variables that have been identified as being associated with severe outcomes. The associations of age and preexisting health conditions with severe outcomes have been confirmed in general populations. [24] [25] [26] There has been more specificity identified within specific populations related to health conditions, [27] [28] [29] but not for specific disability groups. This study makes the important contribution that for people with IDD, and possibly for other disability groups, an element of underlying J o u r n a l P r e -p r o o f health or personal attendant needs may affect COVID-19 outcomes. People with IDD, and with disability in general, have not been identified among the vulnerable health populations who should be considered a priority in emergency preparedness and planning for immunizations.

The data currently available on COVID-19 outcomes among people with IDD in the US is scarce at best. 7,30 Until more thorough data is at hand, efforts to understand and address how the pandemic is affecting this vulnerable population must make use of all available data. 31 This study is now one in a series that has used available data to better define the risks and outcomes for people with IDD, noting some cause for concern.

However, there are limitations. It is possible that the primary characteristics determining COVID-19 outcomes among Californians receiving IDD services are age and pre-existing health conditions, and that type of residence simply appropriates these indicators. Although the California DDS COVID-19 data does provide the age distribution of those served, it does not detail the age distribution by type of service. Thus, we are not able to account for the possible effect of age on COVID-19 outcomes by types of residence. We did compare the overall age distribution of those receiving IDD services to the age distribution for California, 32 and note that when not accounting for possible differences in type of setting, those receiving IDD services were a younger population. This is in line with previous research reporting that people with IDD die ten to twenty years earlier than age-matched peers. 33, 34 J o u r n a l P r e -p r o o f In addition, there is no detailed information about people with IDD living in a family home related to intensity of medical and personal services for comparisons to those living in congregate settings, such as pre-existing conditions, numbers of medications prescribed, or specific treatments. It is important to recognize that some individuals with IDD may be receiving intensive skilled nursing care in a family home, depending on the resources available to the family. This is the case for both people with IDD living within a family home or congregate setting. Availability of skilled nursing care is a proxy for significant health care needs and is only available for congregate settings. Due to these limitations, the precise contributions of age and pre-existing health conditions to COVID-19 outcomes within this population remain unanswered. Though not testable with the data at hand, it is feasible to think that the markedly different COVID-19 outcomes among those with IDD living in their own or a family home in this study may be a result of this population being comparatively younger and having fewer medical conditions than people with IDD in other types of settings. This may especially be the case compared to the ICF-DD settings that serves adults who have comparatively higher prevalence of medical conditions. 35 It also must be emphasized that the data from this study is from California and may not be generalized to other states because of the significant variation in designs of programs, availability of services, and models of service delivery. Among the few states providing information about their citizens with IDD and the pandemic, comparisons are limited by the varied presentations of the data and restricted definitions.

Early studies indicated that COVID-19 may present a greater risk to people with IDD, especially those residing in congregate settings and related to increasing supports and services. 6, 7 Results from this study provide additional information related to the combination of residence and the need for skilled nursing care for people with IDD. The risks of COVID-19 outcomes among people with IDD living in congregate settings may be more severe than for the general population -with diagnosis of COVID-19 more common in settings with increased numbers of residents, and case-fatality more common in settings that provide higher levels of skilled nursing care. When data is available, future research should focus on whether these differences in COVID-19 outcomes persist even when controlling for age and pre-existing conditions. J o u r n a l P r e -p r o o f 

A Call for Better Data on Prevalence and Health Surveillance of People With Intellectual and Developmental Disabilities

Improving Public Health Requires Inclusion of Underrepresented Populations in Research

Physical health of adults with intellectual and developmental disabilities

Medical care for children & adults with developmental disabilities

The State of the States in developmental disabilities

Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis

COVID-19 Outcomes among People with Intellectual and Developmental Disability Living in Residential Group Homes in New York State

COVID-19 Trends Among Adults with Intellectual and Developmental Disabilities (IDD) Living in Residential Group Homes in New York State through

Social determinants of health, emergency department utilization, and people with intellectual and developmental disabilities

Rate of deficit accumulation in home care users with intellectual and developmental disabilities

Applying the HC-IDD Frailty Index to Developmental Services Agency Chart Data

Use of home care services among adults with intellectual and developmental disabilities: does where you live matter? Research and Practice in Intellectual and Developmental Disabilities

Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV

Structural Vulnerability in the United States Revealed in Three Waves of Novel Coronavirus Disease (COVID-19)

Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in

In-home and residential long-term supports and services for persons with intellectual or J o u r n a l P r e -p r o o f developmental disabilities: Status and trends through

Reported positive COVID-19 tests and deaths of regional center consumers

COVID-19 Cases

Living in the community

RULA -Rights Under the Lanterman Act, Living Arrangments for Adults and Children

On Judging the Significance of Differences by Examining the Overlap Between Confidence Intervals

Severe outcomes among patients with coronavirus disease 2019 (COVID-19) -United States

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms

Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study

The Impact of Substance Use Disorder on COVID-19 Outcomes

Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic. Available at SSRN 3633220

The Covid-19 Pandemic and People with Disability

The Public Health Response to the COVID-19 Pandemic for People with Disabilities

State of California Department of Finance

Heterogeneity in age at death for adults with developmental disability

Evidence of Continued Reduction in the Age-at-Death Disparity Between Adults with and without Intellectual and/or Developmental Disabilities